This compound is a salt-like mixture consisting of a difluorophenylpyrrolidine stereoisomer and a hydroxybutanedioic acid component. It is documented as a pharmaceutical intermediate, primarily used in research and manufacturing settings.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1919868-77-1
2-(2,5-Difluorophenyl)pyrrolidine, (R)-
pharmaceutical raw material
2-(2,5-Difluorophenyl)pyrrolidine hydrochloride, (R)-
pharmaceutical intermediate
7-Methoxy-2,4,4-trimethyl-1,3(2H,4H)-isoquinolinedione
pharmaceutical intermediate
Tert-butyl 4-(2-aminoethyl)piperazine-1-carboxylate
pharmaceutical intermediate
4-[4-(5-fluoropyrimidin-2-yl)piperazin-1-yl]aniline
pharmaceutical intermediate
Alfuzosin Impurity 1
pharmaceutical intermediate
(2R)-2-phenylpyrrolidine
research compound
(R)-2-(2-(Methylthio)phenyl)pyrrolidine
pharmaceutical intermediate
(2R)-2-(2,5-difluorophenyl)pyrrolidine;(2R)-2-hydroxybutanedioic acid
KMLXGOHWKMHXAE-SBHYBIRFSA-N
C1C[C@@H](NC1)C2=C(C=CC(=C2)F)F.C([C@H](C(=O)O)O)C(=O)O
—